Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Leukotriene D4 MeSH Descriptor Data 2025


MeSH Heading
Leukotriene D4
Tree Number(s)
D10.251.355.255.100.450.855.461
D10.251.355.310.166.887.855.461
D23.469.050.175.450.725.415
Unique ID
D017998
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D017998
Scope Note
One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)
Entry Term(s)
LTD4
Leukotriene D
Leukotriene D-4
Leukotrienes D
Registry Numbers
73836-78-9
0
CAS Type 1 Name
Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))-
Previous Indexing
SRS-A (1982-1993)
Public MeSH Note
94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
Online Note
use SRS-A to search LEUKOTRIENE D4 & LEUKOTRIENES D 1983-93
History Note
94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
Date Established
1994/01/01
Date of Entry
1993/06/04
Revision Date
2015/06/08
Leukotriene D4 Preferred
Leukotrienes D Broader
page delivered in 0.134s